259 related articles for article (PubMed ID: 17849632)
1. The proper focus for FDA regulations: why the fundamental right to self-preservation should allow terminally ill patients with no treatment options to attempt to save their lives.
Puckett A
SMU Law Rev; 2007; 60(2):635-65. PubMed ID: 17849632
[No Abstract] [Full Text] [Related]
2. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
3. A study in futility: Abigail Alliance for Better Access to Developmental Drugs will not expand access to experimental drugs for the terminally ill.
Ochs A
Seton Hall Law Rev; 2009; 39(2):559-603. PubMed ID: 19462540
[No Abstract] [Full Text] [Related]
4. No way to save a life: allowing terminally ill patients access to drugs that have not completed clinical trials is a dangerous move.
Moss RW
New Sci; 2006 Jun 3-9; 190(2554):21. PubMed ID: 16832956
[No Abstract] [Full Text] [Related]
5. Access before approval--a right to take experimental drugs?
Okie S
N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
[No Abstract] [Full Text] [Related]
6. The terminally ill, access to investigational drugs, and FDA rules.
Blake V
Virtual Mentor; 2013 Aug; 15(8):687-91. PubMed ID: 23937785
[No Abstract] [Full Text] [Related]
7. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
8. In the laboratory of the states: the progress of Glucksberg's invitation to states to address end-of-life choice.
Tucker KL
Mich Law Rev; 2008 Jun; 106(8):1593-612. PubMed ID: 18595217
[TBL] [Abstract][Full Text] [Related]
9. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
Simon LS; Green A
J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
[TBL] [Abstract][Full Text] [Related]
10. Constitutional law--substantive due process--en banc D.C. Circuit rejects fundamental right to experimental medications.--Abigail Alliance for Better Access to Developmental Drugs v. von Eschenbach, 495 F.3d 695 (D.C. Cir. 2007)(en banc), cert. denied, 128 S. Ct. 1069 (2008).
Harv Law Rev; 2008 Apr; 121(6):1685-92. PubMed ID: 18524069
[No Abstract] [Full Text] [Related]
11. Charging for investigational drugs under an investigational new drug application. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40871-900. PubMed ID: 19691172
[TBL] [Abstract][Full Text] [Related]
12. US court rules to allow experimental drugs for dying patients.
Waltz E
Nat Med; 2006 Jun; 12(6):596. PubMed ID: 16760988
[No Abstract] [Full Text] [Related]
13. Should terminally ill patients have access to phase I drugs?
Bristol N
Lancet; 2007 Mar; 369(9564):815-6. PubMed ID: 17366691
[No Abstract] [Full Text] [Related]
14. Right to try?
Lieu CH; Sorkin A; Messersmith WA
J Clin Oncol; 2015 May; 33(13):1518. PubMed ID: 25779561
[No Abstract] [Full Text] [Related]
15. Foreword: can Glucksberg survive Lawrence? Another look at the end of life and personal autonomy.
Kamisar Y
Mich Law Rev; 2008 Jun; 106(8):1453-78. PubMed ID: 18595210
[TBL] [Abstract][Full Text] [Related]
16. Cancer and the constitution--choice at life's end.
Annas GJ
N Engl J Med; 2007 Jul; 357(4):408-13. PubMed ID: 17652658
[No Abstract] [Full Text] [Related]
17. Access for the terminally ill to experimental medical innovations: a three-pronged threat.
Bender S; Flicker L; Rhodes R
Am J Bioeth; 2007 Oct; 7(10):3-6. PubMed ID: 17926208
[No Abstract] [Full Text] [Related]
18. Long-term care: end-of-life issues. Issue brief.
Miller KG
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-25. PubMed ID: 20217925
[No Abstract] [Full Text] [Related]
19. The question remains: are there terminally ill patients who have a constitutional right to physician assistance in hastening the dying process.
Hermann DH
DePaul J Health Care Law; 1997; 1(3):445-93. PubMed ID: 15282883
[No Abstract] [Full Text] [Related]
20. Long-term care: end-of-life issues. End-of-year issue brief.
Jones CA; Miller KG
Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345562
[No Abstract] [Full Text] [Related]
[Next] [New Search]